Community benchmark tests 12,000 AI-designed mini-proteins in living CAR T cells
A global competition named Bits to Binders evaluated 12,000 AI-designed 80-amino acid mini-proteins as the targeting heads for CAR T-cell therapies against human CD20.
The front page of AI-driven biology
Thursday, October 15, 2026Thu, Oct 15
Updated 6:32 PM PT
A global competition named Bits to Binders evaluated 12,000 AI-designed 80-amino acid mini-proteins as the targeting heads for CAR T-cell therapies against human CD20.
Researchers used the structure-informed protein language model ESM-IF1 to pick mutation sites in tobacco Rubisco, the primary enzyme plants use to fix carbon dioxide.
A machine-learning framework augments protein language model representations with structural priors and evolutionary co-variation features derived from an AlphaFold-style trunk.
Researchers combined machine learning with directed evolution to engineer adeno-associated virus (AAV) capsids optimized for exosomal encapsulation, a method used to protect gene therapy delivery vehicles from immune recognition.
Researchers showed that assay-specific fitness variations align within a compact, linear subspace of mutation representation changes produced by protein language models.
Researchers built NuCaliby, a structure-conditioned generative model that designs protein amino-acid sequences together with their corresponding DNA and mRNA nucleotide sequences.
Researchers developed CatFunc, a lightweight protein language model pipeline that classifies how AAA proteins convert ATP chemical energy into mechanical force directly from sequence data.
Researchers have developed peptide-retargeted phosphatases, synthetic fusion proteins that link computationally designed peptide binders to a serine/threonine phosphatase subunit to selectively remove phosphate groups from specific cellular targets.
Bioengineers developed the Catalytic Guidance Engine, an iterative design framework that detunes geometric constraints during diffusion sampling to build complex catalytic sites into de novo proteins.
Researchers introduced two learned discrete latent vocabularies to train autoregressive transformers on protein sequence and structure, replacing conventional residue tokens and coordinates.
Researchers introduced AlphaProtein Novo, a machine-learning pipeline that builds functional enzymes from scratch without starting from natural protein backbones.
Researchers combined molecular simulations and machine learning across four screening rounds to prospect natural hydroxymethylfurfural oxidases for synthesizing the bioplastic precursor 2,5-furandicarboxylic acid (FDCA).
A geometric diffusion model called Zephyr samples conformational ensembles of intrinsically disordered proteins directly from sequence, bypassing the need for slow physics simulations.
Researchers built FLIGHTED, a Bayesian statistical method that converts noisy high-throughput assay readouts into probabilistic fitness landscapes before feeding them into machine-learning models.
Researchers combined amino acid alignments with a structural alphabet, using variational autoencoders and evolutionary energy calculations to map protein sequence variations against structural changes.
Xaira Therapeutics unveiled X-Design, its generative artificial intelligence platform built to design drug-ready antibodies from scratch, along with two early preclinical pipeline candidates.
A systematic benchmark evaluated 4-bit quantization and low-rank adapter fine-tuning, known as QLoRA, across seven protein language models including ESM-2, ProtT5, and Profluent-E1.
Fold'EM combines generative structural priors directly with raw cryo-electron microscopy particle images to infer atomic models, skipping the usual steps of building a 3D density map and fitting a model into it.
Researchers ran AlphaFold2 and AlphaFold-Multimer across 2,812 viral proteomes from 23 viral families, generating high-confidence models for 5,279 heterodimers and 2,749 homodimers.
Proton-PottsMPNN treats protonated and deprotonated amino acids as distinct sequence tokens, allowing researchers to design proteins that bind their targets only at specified acidic pH levels.
DeepUMQA-Selection pairs single-model accuracy scores with shape-recognition structural alignment to pick top predicted multi-protein structures from large candidate pools.
Researchers built BioEvidence, an interface that feeds structural and evolutionary context from standard biology tools into frozen large language models to predict how protein mutations affect function.
Researchers combined high-throughput yeast display screening with AlphaFold3 structural modeling to discover single-domain antibodies that neutralize neurotoxins from multiple snake species.
Researchers built PeTriPPI2, a computational framework that predicts whether two proteins interact by pairing sequence embeddings from ESM-2 with structural features from PeTriBERT.
Google researchers introduced SynthIDBio, a set of methods that embeds detectable digital watermarks directly into AI-generated protein sequences and molecular structures.
Computational design yielded de novo mini-proteins that target Plasmodium falciparum reticulocyte-binding protein homolog 5 (RH5) to block its interaction with human basigin, an essential step in red blood cell invasion.
Researchers introduced MIMOSA, an inference-time framework that constrains generative protein diffusion models to mimic the interaction geometry of known binding partners.
Researchers introduced VenusREM-Harness, a plug-in method that improves mutation fitness predictions from frozen protein foundation models without retraining.
Researchers at the Oxford Protein Informatics Group derived a closed-form correction for a mathematical bias caused by pairing Dropout and LayerNorm layers, a common design in AlphaFold2-style architectures.
Researchers introduced GraPPI, a self-supervised deep learning model designed to represent protein-protein interactions by treating complexes as heterogeneous residual graphs.